Clin2
NCT07855900Likely a fitNot yet recruiting

Survodutide for weight loss in adults without diabetes

Obesity

Part of Hormones & metabolism clinical trials.

This study tests an investigational medicine called survodutide to help adults with overweight or obesity lose weight. If you have tried to lose weight before with diet but haven't had lasting success, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
350 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You are overweight or have obesity.
  • You have tried to lose weight with diet in the past, but it didn't work well enough.
  • You do not have type 1 or type 2 diabetes.
  • Women who can become pregnant must be willing to use effective birth control.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07850050Not yet recruiting· Phase 3
Weight loss study for women in or after menopause

This study tests an investigational drug called survodutide to see if it helps women who are overweight or obese and going through or finished menopause lose weight. If you qualify, you may receive the study drug or a placebo, and the study will track your weight loss over time.

Birmingham, Alabama
NCT07768813Recruiting· Phase 1
Comparing two versions of an injected drug in healthy and overweight people

This trial compares two different versions of an injected study drug (survodutide) to see how they are absorbed by the body. It is open to healthy people and people with overweight or obesity, and it may help researchers find a better way to deliver this treatment.

Mannheim
NCT07850063Not yet recruiting· Phase 3
Heart and liver health study for people with overweight

This study tests a new medicine called survodutide to see if it can improve heart function and structure in people who are overweight and have fatty liver disease. It may help reduce risks related to heart problems.

Peoria, Arizona
NCT07467447Recruiting· Phase 2
Testing a weight-loss drug for people with obesity or overweight

This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.

Shenzhen, Guangdong
NCT07668401Not yet recruiting· Phase 3
Weight loss study for adults in Asia

This study tests an investigational medicine called Zenagamtide to see if it helps people with excess body weight lose weight. It is specifically for adults in Asia who do not have diabetes and have not taken certain weight-loss or diabetes medicines before.

Surat, Gujarat
NCT07822061Recruiting· Phase 3
Weight loss study for people with excess weight

This study tests an investigational medicine for weight loss in people with excess weight. It aims to see how effective the medicine is and may help you lose weight and improve health.

Sapporo, Hokkaido

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.